Esperion Therapeutics | Koszty Operacyjne





Koszty Operacyjne Zmiana Data
AbbVie USD 10.81B 13.45B 2025-12
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Alterity Therapeutics Limited AUD 7.78M 3M 2023-06
Amarin USD 51.37M 14.6M 2025-09
Amgen USD 5.9B 773M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Cipla INR 60.98B 1.06B 2025-12
CSL USD 2.87B 2.85B 2025-06
Cytokinetics USD 168.69M 9.58M 2025-09
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Geron USD 61.11M 376K 2025-09
Grifols EUR 1.77B 22.04M 2025-09
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Heron Therapeutics USD 38.47M 4M 2024-09
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Merck USD 10.16B 558M 2025-12
Minerva Neurosciences USD 4.52M 155.46K 2024-12
Moderna USD 1.28B 232M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 207.52M 6.21M 2025-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
United Therapeutics USD 6.59B 6.07B 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09


Esperion Therapeutics Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.